CLBT's Rebound Just Reached the One Level That Decides Whether the Crash Continues

Three weeks after a 29% one-day plunge, Cellebrite has clawed back to $12 — the round number where discount-hunters' gains and pre-crash shareholders' exits collide. What happens here separates a repair from a dead-cat bounce.

Cellebrite (CLBT) is trading at $11.94, up 2.75% on the day, as of the most recent Thursday reading — with an intraday high of $11.99. For a stock that lost a third of its value in a single session last month, that recovery looks like someone quietly buying the dip.

The recovery is real, but it is hitting the exact wall the crash built. And on a chart that is still broken, the wall tells you whether the buyers are winning or are about to become the trapped inventory.

The crash left a ceiling

On August 13, Cellebrite reported second-quarter revenue of $131 million and annual recurring revenue of $508 million — top-line growth that missed the bottom end of its own guidance — and cut its full-year ARR target to $550–560 million. The same morning it announced a CEO transition, with Shiven Ramji, who joined in May, replacing Thomas Hogan.

The market treated those as one event. Shares crashed 29.2% to close at $10.80 on volume of roughly 36.5 million shares — about fourteen times its normal pace — carving a day range from $9.58 to $10.83. Since then the stock has been repairing: from that low it has climbed back above the entire crash-day range and is now pressing into the low $12s.

Here is what makes this a contest rather than a recovery. The stock remains below both its 50-day moving average near $14.04 and its 200-day at $14.73 — two declining trendlines that define the overhead supply. A bounce that can't clear those is a bounce inside a broken chart, not a breakout from one.

The buyers today aren't the ones who mattered

Now look at who is doing the buying. On today's up day, the medium- and large-order buckets show net outflow — roughly $0.8 million more flowing out through those channels than in — while the retail bucket is essentially even. Price is climbing on smaller-size participation while the larger participant set trims into the strength.

That matters because a bounce that advances only on small orders, into a zone where big hands are distributing, tends to run out of fuel unless the big orders flip. It is not proof of direction; it is evidence of who is carrying the move right now — and it is not the set of participants that pushed the stock down.

Add the overhang: an analyst downgrade to sell, a shareholder investigation launched over the guidance cut, and insider selling reported in the run-up. None of these moves price by itself, but together they mean the sellers have reasons to keep supplying shares into any rally back toward their exit levels.

The line that matters: $12

Everything now runs through $12. Today's high is $11.99, so the stock is knocking on it in real time. Above it sits the unfilled portion of the August collapse — the gap that runs toward the low-to-mid $13s — and then the declining 50-day near $14.

The mechanism on either side:

• Hold and reclaim $12: dip-buyers who owned the crash low are at a small gain and may hold, and late shorts who pressed the post-earnings breakdown get squeezed. That opens the run toward the $13 gap zone and the 50-day — the first real repair target, roughly 10–17% higher.
• Reject at $12: the round-number ceiling, reinforced by descending trendline supply and the distribution happening into the bounce, catches the bargain hunters. Buyers who bought the recovery near $12 become the trapped inventory, and a fade back below the $10.80 crash-day close reopens the route to a retest of the $9.58 low.

Distance from invalidation is tight: the stock is only about $2 above the crash low, and it would take only a failed close below $12 and a slide back under $11 to break the repair structure. That asymmetry — a short ride to major resistance against a fast path back to the lows — is exactly why this setup is a deliberation, not a trigger.

Verdict

Hold $12 and the recovery stays in play, with the gap and the 50-day as the next test. Lose $12 and the bounce is a bear trap closing on this week's buyers, and the chart's next obvious destination is a retest of the $9.58 low.

The level resolves the crash's third question: is this a repair, or the pause before a second leg down? Right now the chart says not enough information has changed to call it. $12 decides.

Data as of the September 4, 2026 market snapshot. Cellebrite's digital-investigation software is used across roughly 7,000 law-enforcement, defense and intelligence organizations, but none of that resets the decision the chart is forcing at $12.